Product Introduction

Pharmigene pharmacogenomics detection kit series(Pharmigene PG1502 detection kit、Pharmigene PG5801 detection kit、Pharmigene PG3101 detection kit、Pharmigene PG1301 detection kit、Pharmigene PG1639 detection kit、Pharmigene PG0430 detection kit、Pharmigene PG1075 detection kit、Pharmigene PG0681 detection kit、Pharmigene PG0430 detection kit)

Drug sensitivity is the abnormal reaction of human immune system caused by medication. Any medication may has the possibility to induce the immune storm – drug sensitivity. The symptoms of drug sensitivity is vary like hives, rash or fever. Sometimes, server events such as Stevens-Johnson syndrome or Toxic epidermal necrolysis can occur and may cause death.

Drug metabolism is the pathway to break down drug compounds inside body into the functional molecules. Drug metabolism rates vary among patients and the speed can be determined by gene. Different genotypes can cause huge difference dosage of drug among patients. For example, warfarin, a common use anti-coagulant can dose more than 6 times higher in mutant type patient than in wide type one.

"Pharmacogenomics is the study of how genes affect a person's response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person's genetic makeup."

Since the completion of the human genome sequences, personalized medicine based on an individual's genomic profile is now possible. Some patients with certain genetic markers may be a thousand-fold more likely to develop a severe adverse reaction to a specific drug. Using a companion genetic IVD test to offer a safer and more effective drug for patients has become a reality. Browse through our website for more information.

PharmiGENE was established in 2005 and funded by venture capitalists and angel investors. Our goal is to innovate and commercialize diagnostic tests that enable everyone to be better informed about his/her genetic makeup and to make decisions that can better their health. We have licensed from Academia Sinica the exclusive rights to key technologies relating to genetic markers associated with adverse drug reactions caused by several popular pharmaceutical products.

© 2023 Taiwan-Thailand Smart Healthcare Conference
Webnode 提供技術支援 Cookies
免費建立您的網站! 此網站是在 Webnode 上建立的。今天開始免費建立您的個人網站 立即開始